nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—psoriasis—ankylosing spondylitis	0.954	1	CtDrD
Tazarotene—Localized exfoliation—Triamcinolone—ankylosing spondylitis	0.0021	0.0456	CcSEcCtD
Tazarotene—Leukoderma—Prednisolone—ankylosing spondylitis	0.00145	0.0314	CcSEcCtD
Tazarotene—Leukoderma—Triamcinolone—ankylosing spondylitis	0.00133	0.0289	CcSEcCtD
Tazarotene—Leukoderma—Methylprednisolone—ankylosing spondylitis	0.00133	0.0288	CcSEcCtD
Tazarotene—Leukoderma—Dexamethasone—ankylosing spondylitis	0.00121	0.0262	CcSEcCtD
Tazarotene—Leukoderma—Betamethasone—ankylosing spondylitis	0.00121	0.0262	CcSEcCtD
Tazarotene—Leukoderma—Prednisone—ankylosing spondylitis	0.00105	0.0228	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Triamcinolone—ankylosing spondylitis	0.000953	0.0206	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Methylprednisolone—ankylosing spondylitis	0.000951	0.0206	CcSEcCtD
Tazarotene—Leukoderma—Methotrexate—ankylosing spondylitis	0.00088	0.0191	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Dexamethasone—ankylosing spondylitis	0.000865	0.0187	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Betamethasone—ankylosing spondylitis	0.000865	0.0187	CcSEcCtD
Tazarotene—Blister—Prednisolone—ankylosing spondylitis	0.000855	0.0185	CcSEcCtD
Tazarotene—Blister—Triamcinolone—ankylosing spondylitis	0.000786	0.017	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Prednisone—ankylosing spondylitis	0.00078	0.0169	CcSEcCtD
Tazarotene—Stinging—Prednisolone—ankylosing spondylitis	0.000761	0.0165	CcSEcCtD
Tazarotene—Acne—Prednisolone—ankylosing spondylitis	0.000732	0.0159	CcSEcCtD
Tazarotene—Blister—Betamethasone—ankylosing spondylitis	0.000714	0.0154	CcSEcCtD
Tazarotene—Blister—Dexamethasone—ankylosing spondylitis	0.000714	0.0154	CcSEcCtD
Tazarotene—Stinging—Triamcinolone—ankylosing spondylitis	0.0007	0.0151	CcSEcCtD
Tazarotene—Blood triglycerides increased—Prednisone—ankylosing spondylitis	0.000684	0.0148	CcSEcCtD
Tazarotene—Acne—Triamcinolone—ankylosing spondylitis	0.000674	0.0146	CcSEcCtD
Tazarotene—Acne—Methylprednisolone—ankylosing spondylitis	0.000672	0.0145	CcSEcCtD
Tazarotene—Stinging—Betamethasone—ankylosing spondylitis	0.000635	0.0137	CcSEcCtD
Tazarotene—Stinging—Dexamethasone—ankylosing spondylitis	0.000635	0.0137	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Methotrexate—ankylosing spondylitis	0.000629	0.0136	CcSEcCtD
Tazarotene—Acne—Dexamethasone—ankylosing spondylitis	0.000611	0.0132	CcSEcCtD
Tazarotene—Acne—Betamethasone—ankylosing spondylitis	0.000611	0.0132	CcSEcCtD
Tazarotene—Inflammation—Methylprednisolone—ankylosing spondylitis	0.000583	0.0126	CcSEcCtD
Tazarotene—Dermatitis contact—Triamcinolone—ankylosing spondylitis	0.00056	0.0121	CcSEcCtD
Tazarotene—Skin exfoliation—Triamcinolone—ankylosing spondylitis	0.000541	0.0117	CcSEcCtD
Tazarotene—Skin exfoliation—Methylprednisolone—ankylosing spondylitis	0.00054	0.0117	CcSEcCtD
Tazarotene—Burning sensation—Methotrexate—ankylosing spondylitis	0.000539	0.0117	CcSEcCtD
Tazarotene—Acne—Prednisone—ankylosing spondylitis	0.000532	0.0115	CcSEcCtD
Tazarotene—Dermatitis contact—Dexamethasone—ankylosing spondylitis	0.000508	0.011	CcSEcCtD
Tazarotene—Dermatitis contact—Betamethasone—ankylosing spondylitis	0.000508	0.011	CcSEcCtD
Tazarotene—Skin exfoliation—Betamethasone—ankylosing spondylitis	0.000491	0.0106	CcSEcCtD
Tazarotene—Skin exfoliation—Dexamethasone—ankylosing spondylitis	0.000491	0.0106	CcSEcCtD
Tazarotene—Dermatitis bullous—Prednisolone—ankylosing spondylitis	0.000468	0.0101	CcSEcCtD
Tazarotene—Dermatitis bullous—Triamcinolone—ankylosing spondylitis	0.00043	0.00932	CcSEcCtD
Tazarotene—Skin exfoliation—Prednisone—ankylosing spondylitis	0.000428	0.00926	CcSEcCtD
Tazarotene—Skin discolouration—Methotrexate—ankylosing spondylitis	0.000414	0.00897	CcSEcCtD
Tazarotene—Dry skin—Prednisolone—ankylosing spondylitis	0.00041	0.00888	CcSEcCtD
Tazarotene—Dermatitis bullous—Betamethasone—ankylosing spondylitis	0.000391	0.00846	CcSEcCtD
Tazarotene—Dermatitis bullous—Dexamethasone—ankylosing spondylitis	0.000391	0.00846	CcSEcCtD
Tazarotene—Inflammation—Methotrexate—ankylosing spondylitis	0.000386	0.00835	CcSEcCtD
Tazarotene—Skin exfoliation—Methotrexate—ankylosing spondylitis	0.000357	0.00774	CcSEcCtD
Tazarotene—Dry skin—Dexamethasone—ankylosing spondylitis	0.000342	0.00741	CcSEcCtD
Tazarotene—Dry skin—Betamethasone—ankylosing spondylitis	0.000342	0.00741	CcSEcCtD
Tazarotene—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000311	0.00673	CcSEcCtD
Tazarotene—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00031	0.0067	CcSEcCtD
Tazarotene—Dry skin—Prednisone—ankylosing spondylitis	0.000298	0.00645	CcSEcCtD
Tazarotene—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000286	0.00619	CcSEcCtD
Tazarotene—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000285	0.00618	CcSEcCtD
Tazarotene—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000285	0.00616	CcSEcCtD
Tazarotene—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000284	0.00615	CcSEcCtD
Tazarotene—Erythema—Prednisolone—ankylosing spondylitis	0.000269	0.00583	CcSEcCtD
Tazarotene—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00026	0.00562	CcSEcCtD
Tazarotene—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00026	0.00562	CcSEcCtD
Tazarotene—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000258	0.00559	CcSEcCtD
Tazarotene—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000258	0.00559	CcSEcCtD
Tazarotene—Erythema—Triamcinolone—ankylosing spondylitis	0.000248	0.00536	CcSEcCtD
Tazarotene—Erythema—Methylprednisolone—ankylosing spondylitis	0.000247	0.00535	CcSEcCtD
Tazarotene—Discomfort—Prednisolone—ankylosing spondylitis	0.000227	0.00491	CcSEcCtD
Tazarotene—Haemoglobin—Prednisone—ankylosing spondylitis	0.000226	0.00489	CcSEcCtD
Tazarotene—Haemorrhage—Prednisone—ankylosing spondylitis	0.000225	0.00487	CcSEcCtD
Tazarotene—Erythema—Dexamethasone—ankylosing spondylitis	0.000225	0.00487	CcSEcCtD
Tazarotene—Erythema—Betamethasone—ankylosing spondylitis	0.000225	0.00487	CcSEcCtD
Tazarotene—Oedema—Prednisolone—ankylosing spondylitis	0.00022	0.00476	CcSEcCtD
Tazarotene—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000214	0.00464	CcSEcCtD
Tazarotene—Discomfort—Triamcinolone—ankylosing spondylitis	0.000208	0.00451	CcSEcCtD
Tazarotene—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000208	0.0045	CcSEcCtD
Tazarotene—Oedema—Triamcinolone—ankylosing spondylitis	0.000202	0.00438	CcSEcCtD
Tazarotene—Erythema—Prednisone—ankylosing spondylitis	0.000196	0.00424	CcSEcCtD
Tazarotene—Discomfort—Betamethasone—ankylosing spondylitis	0.000189	0.00409	CcSEcCtD
Tazarotene—Discomfort—Dexamethasone—ankylosing spondylitis	0.000189	0.00409	CcSEcCtD
Tazarotene—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000189	0.00409	CcSEcCtD
Tazarotene—Pain—Prednisolone—ankylosing spondylitis	0.000188	0.00407	CcSEcCtD
Tazarotene—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000188	0.00407	CcSEcCtD
Tazarotene—Oedema—Betamethasone—ankylosing spondylitis	0.000183	0.00397	CcSEcCtD
Tazarotene—Oedema—Dexamethasone—ankylosing spondylitis	0.000183	0.00397	CcSEcCtD
Tazarotene—Pain—Triamcinolone—ankylosing spondylitis	0.000173	0.00374	CcSEcCtD
Tazarotene—Discomfort—Prednisone—ankylosing spondylitis	0.000165	0.00357	CcSEcCtD
Tazarotene—Erythema—Methotrexate—ankylosing spondylitis	0.000164	0.00354	CcSEcCtD
Tazarotene—Oedema—Prednisone—ankylosing spondylitis	0.00016	0.00346	CcSEcCtD
Tazarotene—Pain—Dexamethasone—ankylosing spondylitis	0.000157	0.0034	CcSEcCtD
Tazarotene—Pain—Betamethasone—ankylosing spondylitis	0.000157	0.0034	CcSEcCtD
Tazarotene—Pruritus—Triamcinolone—ankylosing spondylitis	0.000143	0.0031	CcSEcCtD
Tazarotene—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000143	0.00309	CcSEcCtD
Tazarotene—Rash—Prednisolone—ankylosing spondylitis	0.000139	0.003	CcSEcCtD
Tazarotene—Dermatitis—Prednisolone—ankylosing spondylitis	0.000139	0.003	CcSEcCtD
Tazarotene—Discomfort—Methotrexate—ankylosing spondylitis	0.000138	0.00298	CcSEcCtD
Tazarotene—Pruritus—Betamethasone—ankylosing spondylitis	0.00013	0.00281	CcSEcCtD
Tazarotene—Pruritus—Dexamethasone—ankylosing spondylitis	0.00013	0.00281	CcSEcCtD
Tazarotene—Rash—Triamcinolone—ankylosing spondylitis	0.000128	0.00276	CcSEcCtD
Tazarotene—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000127	0.00276	CcSEcCtD
Tazarotene—Rash—Methylprednisolone—ankylosing spondylitis	0.000127	0.00275	CcSEcCtD
Tazarotene—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000127	0.00275	CcSEcCtD
Tazarotene—Rash—Betamethasone—ankylosing spondylitis	0.000116	0.0025	CcSEcCtD
Tazarotene—Rash—Dexamethasone—ankylosing spondylitis	0.000116	0.0025	CcSEcCtD
Tazarotene—Dermatitis—Betamethasone—ankylosing spondylitis	0.000116	0.0025	CcSEcCtD
Tazarotene—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000116	0.0025	CcSEcCtD
Tazarotene—Pain—Methotrexate—ankylosing spondylitis	0.000114	0.00247	CcSEcCtD
Tazarotene—Pruritus—Prednisone—ankylosing spondylitis	0.000113	0.00245	CcSEcCtD
Tazarotene—Rash—Prednisone—ankylosing spondylitis	0.000101	0.00218	CcSEcCtD
Tazarotene—Dermatitis—Prednisone—ankylosing spondylitis	0.000101	0.00218	CcSEcCtD
Tazarotene—Pruritus—Methotrexate—ankylosing spondylitis	9.45e-05	0.00205	CcSEcCtD
Tazarotene—Rash—Methotrexate—ankylosing spondylitis	8.42e-05	0.00182	CcSEcCtD
Tazarotene—Dermatitis—Methotrexate—ankylosing spondylitis	8.41e-05	0.00182	CcSEcCtD
